Apadenoson
Apadenoson Uses, Dosage, Side Effects, Food Interaction and all others data.
Apadenoson is a selective A2a adenosine receptor agonist designed for use as a pharmacologic stress agent in cardiac perfusion imaging studies. It is developed by Bristol-Myers Squibb and is in phase II of clinical trials.
Trade Name | Apadenoson |
Generic | Apadenoson |
Apadenoson Other Names | Apadenoson |
Type | |
Formula | C23H30N6O6 |
Weight | Average: 486.529 Monoisotopic: 486.22268271 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Investigated for use/treatment in cardiovascular disorders and inflammatory disorders (unspecified).
How Apadenoson works
BMS068645 is designed to selectively stimulate the A2a adenosine receptor responsible for coronary vasodilation. Research to date suggests that this compound could potentially reduce or eliminate side effects associated with currently available pharmacologic stress agents that are not selective for the A2a adenosine receptor.
Innovators Monograph
You find simplified version here Apadenoson